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Listeria Placental Infection
José A. Vázquez-Boland, Emilia Krypotou, Mariela Scortti
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University of Edinburgh, Edinburgh, United Kingdom
ABSTRACT The Gram-positive facultative intracellular bacterium Listeria monocyto-
genes is the causative agent of listeriosis, a severe food-borne infection. Pregnant
women are at risk of contracting listeriosis, which can potentially lead to miscar-
riage, stillbirth, preterm birth, and congenital neonatal infections. While other sys-
temic bacterial infections may result in adverse pregnancy outcomes at comparable
frequencies, L. monocytogenes has particular notoriety because fetal complications
largely occur in the absence of overt illness in the mother, delaying medical inter-
vention. Here, we brieﬂy review the pathophysiology and mechanisms of maternofe-
tal listeriosis, discussed in light of a recent mBio report on Listeria transplacental in-
fection in a nonhuman primate model.
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Although many human systemic bacterial infections may result in miscarriage orstillbirth, unlike Listeria monocytogenes, the causative agents are not considered
primarily abortifacient. For example, recent data from the United Kingdom show that
of a cohort of 75 pregnant women with invasive Haemophilus inﬂuenzae infection, 63%
had fetal loss (1). In comparison, with a similar incidence, only 40% of pregnancy-
associated listeriosis cases resulted in spontaneous abortion, stillbirth, or neonatal
death in the same geographic area (2). Other examples include Brucella, Campylobacter,
Coxiella, or Salmonella, to name a few; while not recognized as part of the TORCH
(toxoplasmosis, other infections, rubella, cytomegalovirus, and herpes simplex virus)
group, all these pathogens may lead to adverse fetal outcome in pregnant women
(3–6) and are also well-known causes of septic abortion in farm animals (7). It has been
suggested that essentially any invasive bacteria with the ability to survive within host
cells can potentially colonize the placenta and fetus via the hematogenous route (8).
What then makes L. monocytogenes stand out as a notorious miscarriage-associated
microbe? One could argue that this is largely due to perception, owing to the
inapparent or mild clinical course of maternal infection before the onset of obstetric
signs. This is in contrast to other systemic infections, where fetal complications are
mainly regarded as secondary to the mother’s illness.
The absence of obvious outward manifestations preceding listerial miscarriage has
been experimentally observed in a study with intragastrically (i.g.) infected cynomolgus
macaques recently published by Wolfe et al. in mBio (9). Similar ﬁndings were previ-
ously reported in rhesus macaques (10, 11), conﬁrming that the lack of speciﬁc
prodromal signs appears to be characteristic of maternofetal listeriosis. With a similar
hemochorial, villous, discoidal placenta and reproductive cycle, nonhuman primates
offer a suitable model to study human reproduction and related disorders (12, 13).
Macaques are naturally susceptible to L. monocytogenes infection, with clinical out-
comes in pregnant monkeys mirroring those in human maternofetal listeriosis. This
includes miscarriage or stillbirth in late pregnancy (14) (in pregnant women mostly
during late second/third trimester [2, 15]).
Timing of listerial miscarriage. The study by Wolfe et al. (9) is interesting in that
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the monkeys were inoculated in early gestation (single i.g. dose of 107 CFU between
gestation days [GD] 36 to 46, term is GD 165), and all four exposed animals miscarried.
In contrast, in an earlier study, Smith et al. (11) observed only six stillbirths among 23
late pregnancies following i.g. exposure of macaques at around GD 110. Wolfe et al.
concluded that the macaque’s maternal-fetal interface may be particularly sensitive to
Listeria infection in early pregnancy and that there might be a greater, unrecognized
risk of listerial miscarriage in the ﬁrst trimester of gestation (9).
However, careful analysis of the existing data for macaques indicates that the
suggested increased susceptibility in early pregnancy (9) may be more apparent than
real, due to the high experimental infection dose used. In late pregnancy monkeys,
Smith et al. (11) observed 16.6% stillbirths after i.g. exposure to 103 to 104 L. monocy-
togenes CFU, 28.6% stillbirths when using 105 to 106 CFU, whereas the only monkey
administered 107 CFU, i.e., the same dose as Wolfe et al. (9) used, delivered a stillborn
fetus. No adverse fetal outcomes were observed with a 102 dose. For a given single-
dose L. monocytogenes inoculum, a higher rate of blood-borne colonization per tissue
mass is to be expected for a smaller uteroplacental unit than for a signiﬁcantly
more-developed one. An overwhelming placental infection in Wolfe et al. is supported
by the acute course and short incubation period before fetal demise, only 7 to 13 days
postinoculation (9) compared to an average of 47 days until stillbirth in the Smith et al.
study (11). The latter is more in keeping with the typical incubation period of mater-
nofetal listeriosis in humans (16), generally associated with lower levels of exposure to
L. monocytogenes according to outbreak data (5  104 CFU/g in the incriminated food
[17]; 1.9  106 estimated dose for 50% listerial perinatal morbidity [18]).
A number of factors may explain the predominant presentation of maternofetal
listeriosis in late pregnancy. For example, the human placenta is thought to become
truly hemochorial only in the second trimester (19). This late shift in the nature of the
maternofetal interface appears to be unique to great apes. In the macaque, intervillous
maternal circulation is established as early as 3 weeks after conception (12, 13), which
together with an earlier invasion of spiral arteries by the extravillous trophoblast (EVT)
(12) (the primary placental cellular target of L. monocytogenes; see below) (Fig. 1) may
contribute to explain the exquisite susceptibility noted by Wolfe et al. (9). The impor-
tance of the placental conﬁguration is unclear, however, because listerial abortion in
ruminants is also predominantly observed in late pregnancy (7, 20) despite having a
different type of placentation (epitheliochorial, with the maternal and fetal circulations
physically separated by six tissue layers) (13).
Other possible explanations include the following: (i) predominance of low-level
infections requiring a protracted incubation period, where the placenta itself may
become a reservoir for maternal reinfection and ampliﬁcation of the bacterial load (21);
(ii) progressive increase in uterine blood ﬂow (and hence exposure of the placenta to
blood-borne listeriae) (Fig. 2) relative to the overall cardiac output; (iii) possible exac-
erbation of critical immune tolerance mechanisms at the maternal-fetal interface in late
gestation; (iv) physiological burden of advanced pregnancy, as suggested by the
observation that pregnant women carrying multiple fetuses are at greater risk of
listeriosis (22); and (v) fetal death during early gestation being more likely to go
unreported or remaining etiologically undiagnosed.
Mechanism of placental colonization and dissemination to the fetus. The
high-dose infection used by Wolfe et al. caused an extensive neutrophilic inﬂammatory
response with disruption of the maternal-fetal barrier of the macaques (9). Vasculitis,
thrombosis, and necrosis of the decidual spiral arteries and the presence of bacteria in
the intervillous maternal circulation, villous capillaries, and umbilical cord were consis-
tently observed (Fig. 1B). While inﬂammation-mediated hematogenous transmission to
the fetus may prevail in an acute or advanced placental infection, the importance of this
dissemination pathway at the initial stages of the process or in cases of low-level
infections is less clear. L. monocytogenes is an actively invasive pathogen endowed with
a stealthy actin-based cell-to-cell spreading mechanism that bypasses the dependency
on cell/tissue damage for successful dissemination while allowing escape from immune
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control (23) (Fig. 1A). The key importance of this cell-to-cell spread mechanism in
transplacental colonization has been demonstrated in vivo in nonprimate animal
models using L. monocytogenes mutants lacking the virulence factor responsible for it,
the actin-polymerizing protein ActA (24, 25).
The primary hematogenous entry route to the placenta (Fig. 2) is more controversial.
Studies of guinea pigs, gerbils, and mice show a contributing yet dispensable role for
the listerial invasins InlA and InlB (required for internalization into nonphagocytic host
cells but not for uptake by professional phagocytes) in placental and fetal colonization
(24, 26, 27). Thus, direct invasion by extracellular bacteria seems less likely to be the
main mechanism than cell-to-cell spread from infected maternal phagocytes trafﬁcking
to the placenta (21) (Fig. 1A). The predominance of one mechanism over the other may
critically depend on the infectious dose and degree of infection of the primary target
organs (liver and spleen) after listerial intestinal translocation (Fig. 2).
Placental tropism? Wolfe et al. (9) observed substantially larger bacterial loads in
the decidua and placenta, umbilical cord, amniotic ﬂuid, and fetal tissues (107 to
108 CFU) compared to the maternal nonreproductive tissue (liver, spleen, and lymph
node; 105 CFU). This was interpreted as a demonstration of the tropism of L. mono-
FIG 1 Listeria transplacental infection. (Top) A pregnant human uterus and schematic of the maternal-fetal interface.
Anchoring and ﬂoating villi are represented. (Bottom) Magniﬁed diagrams of an anchoring villus and its main structural and
cellular components illustrating two transplacental invasion scenarios. (A) Low-level infection with stealthy, mainly cell-to-cell
spread-based transplacental dissemination; (B) acute infection with strong inﬂammatory response, major disruption of the
integrity of the placental barrier with degeneration of syncytiotrophoblast, and signiﬁcant hematogenous dissemination. The
diagram in panel A shows the uterine decidua (DD), the end of a spiral artery (SA) from which maternal blood ﬂows into
the intervillous space (IS), and a chorionic villous tree lined by the syncytiotrophoblast (ST) with underlying progenitor
cytotrophoblast (CT) cells and a basement membrane (BM). CT cells penetrate into the decidua to anchor the villi in the uterus
and invade the maternal arteries to allow blood extravasation into the IS. The villous stroma (STR) contains fetal capillaries (FC)
that are located closer to the villous surface as pregnancy advances. Panel A illustrates the two main hematogenous placental
invasion pathways: (a) actin-based cell-to-cell spread from infected phagocytes that trafﬁc from primary infectious foci in
maternal organs to the placenta (Fig. 2); (b) invasion of the trophoblast by free blood-borne listeriae. Bacteria are shown in
yellow (not drawn to scale).
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cytogenes for the gravid uterus (9). Alternatively, it may simply reﬂect the relative
permissiveness of the placenta to listerial infection compared to other (immunologi-
cally) more restrictive maternal tissues and organs, i.e., “passive tropism.” The fetally
derived cytotrophoblast which forms the maternal-fetal interface, particularly the in-
vading EVT cells that penetrate into the decidua and the maternal spiral arteries from
the anchoring villi, appear to be the primary target for L. monocytogenes placental
colonization (24, 25, 28, 29) (Fig. 1). Trophoblast cells lack class I HLA-A and HLA-B
antigens and class II antigens while expressing nonclassical HLA class I molecules,
dampening allorecognition by uterine NK cells and T cells (30–32). This and other
placental immune tolerance mechanisms prevent the rejection of the semiallogenic
fetus but at the same time may provide a protected sanctuary for the proliferation of
intracellular pathogens like L. monocytogenes, ultimately depending on T-cell-mediated
immunity for clearance (33). Consistent with the rare cooccurrence of central nervous
system (CNS) involvement in maternofetal listeriosis (0.01%) (15), neurological signs
were never observed in experimentally infected pregnant macaques (9–11) despite
listerial CNS infection having a shorter incubation period (1 to 14 days) (16). In an
immunocompetent pregnant mother, this may reﬂect competition between a permis-
sive placenta and a less permissive blood-brain barrier in allowing the establishment of
limited numbers of circulating listeriae (Fig. 2). The fact that the placenta and fetus are
also preferential infection sites for L. monocytogenes in ruminants despite the structur-
ally and cellularly distinct interhemal barrier argues against the implication of speciﬁc
FIG 2 Pathophysiology of food-borne listeriosis. L. monocytogenes bacteria cross the epithelial barrier of
the intestine, translocate to the mesenteric lymph nodes, and reach their primary target organs, i.e., liver
and spleen. There they establish infectious foci that in an immunocompetent individual are efﬁciently
cleared by cell-mediated immunity. In adult people with no predisposing conditions, the process is
largely subclinical. In this population, exposure to larger infective doses may cause febrile gastroenteritis
and, in rare cases, invasive disease. In immunocompromised adults and elderly people who are unable
to mount an efﬁcient T-cell-mediated immune response, the primary infectious foci are inadequately
resolved and Listeria bacteria may be released to the bloodstream. This results in febrile bacteremia and,
eventually, invasive infection of the brain. In pregnant women, L. monocytogenes colonizes the uterus in
addition to the liver and spleen. While the infection is controlled in the latter organs, the placental
immune tolerance mechanisms provide a permissive niche for the proliferation of L. monocytogenes.
Bacteria from the placental reservoir released to the bloodstream may reinfect the mother’s liver and
spleen, contributing to infection maintenance and ampliﬁcation (21). Transplacental dissemination to the
fetus results in abortion, stillbirth, or neonatal sepsis. A late-onset congenital form is also observed in
neonates, often accompanied by meningitis. Based on an original depiction in reference 38.
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targeting mechanisms (unless involving a conserved, promiscuous host receptor); it
suggests rather that placental invasion depends on general intrinsic features of the
Listeria host-pathogen interaction (such as, e.g., cell-to-cell spread in an immunologi-
cally relatively permissive environment).
The above does not exclude the existence of L. monocytogenes determinants
facilitating establishment and proliferation in the maternal reproductive tract and
placenta. According to recent data in guinea pigs, a listerial protein of the internalin
family, InlP, which is generally conserved in L. monocytogenes, appears to speciﬁcally
aid placental colonization (34). Virulence heterogeneity among L. monocytogenes iso-
lates is well documented, and speciﬁc “hypervirulent” clonal complexes have been
epidemiologically and experimentally associated with invasive (placental and CNS
indistinctly) listeriosis (35). Anecdotal evidence hints at the possibility that particular
strains might be more prone to cause maternofetal infections versus other clinical
presentations. Thus, some listeriosis outbreaks, associated with a speciﬁc L. monocyto-
genes strain, have an unusually high frequency of maternal-perinatal cases (36, 37). In
ruminants, maternofetal and CNS forms of the disease seldom occur simultaneously in
the same herd outbreak (20, 38). Interestingly, considered together, the studies by
Wolfe et al. (9) and Smith et al. (10, 11) show that two strains associated with
maternofetal listeriosis cases in humans or primates consistently caused miscarriage in
experimentally infected macaques with an i.g. dose of 107, while two other strains
involved in human outbreaks with a low frequency of maternofetal cases did not.
Speciﬁcally, a L. monocytogenes strain (ScottA) from a listeriosis outbreak with few
pregnancy-related cases (7 of 42) (39) caused stillbirth at a dose of 1010 (1/1) but not
108 (0/1) unless as part of a mix with isolates associated with maternofetal infections
(2/2) (10). Although based on very limited evidence and far from conclusive, these data
show a trend that warrants further investigation.
As brieﬂy outlined here, many areas still remain obscure in our understanding of
maternofetal listeriosis. Key points for attention include the impact of the bacterial dose
on placental infection dynamics, the pathophysiology and determinants of transpla-
cental invasion, and the potential involvement of tropism factors. Also requiring
clariﬁcation is the role of early immune signaling events prior to transplacental colo-
nization as a precipitating factor in fetal demise (40). Experiments in relevant animal
models, including macaques closely replicating the human system, should prove
invaluable for illuminating the detailed mechanisms of placental listeriosis and other
aspects of Listeria pathogenesis.
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